Industry · NAICS 325412
Top Pharmaceutical Preparation Manufacturing federal contractors (FY2027)
The 25 companies winning the most Pharmaceutical Preparation Manufacturing federal contract dollars in FY2027, totaling $100.34M in obligations. Data from USAspending.gov.
Top vendors by obligation
| 1 | MCKESSON CORPORATION | $30.24M |
| 2 | CARDINAL HEALTH 414, LLC | $15.47M |
| 3 | PROGENICS PHARMACEUTICALS INC | $12.49M |
| 4 | NOVARTIS PHARMACEUTICALS CORPORATION | $9.14M |
| 5 | OPTUM INFUSION SERVICES 308, LLC | $4.88M |
| 6 | PETNET SOLUTIONS, INC. | $3.37M |
| 7 | EXELAN PHARMACEUTICALS INC | $3.3M |
| 8 | JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | $2.67M |
| 9 | TELIX PHARMACEUTICALS US INC | $2.45M |
| 10 | SOFIE CO. | $2.29M |
| 11 | RLS (USA) INC. | $1.69M |
| 12 | BRACCO DIAGNOSTICS INC. | $1.62M |
| 13 | NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC | $1.44M |
| 14 | BOSTON SCIENTIFIC CORP | $1.21M |
| 15 | CLINICAL PHARMACY SERVICES, INC. | $1.2M |
| 16 | MEDI-PHYSICS, INC. | $1.1M |
| 17 | BRISTOL-MYERS SQUIBB COMPANY | $1.07M |
| 18 | VALNEVA USA, INC. | $787.39K |
| 19 | PHARMALOGIC HOLDINGS CORP. | $732.85K |
| 20 | NUMEDRX PHARMACY SOLUTIONS LLC | $643.18K |
| 21 | UNIVERSITY OF OKLAHOMA | $628.73K |
| 22 | ADVANCED ACCELERATOR APPLICATIONS USA INC | $570.69K |
| 23 | TRILLAMED LLC | $505.42K |
| 24 | ASD SPECIALTY HEALTHCARE, LLC | $458.65K |
| 25 | JANSSEN BIOTECH INC | $384.72K |
Expiring Pharmaceutical Preparation Manufacturing contracts
15 contracts in NAICS 325412 with an end date still ahead, worth $29.21M together. The whole list →
| Ends | Contract | Incumbent | Value |
|---|---|---|---|
| 2026-11-16 | 36C24226N0309 | OPTUM PHARMACY 801, INC. | $269,557 |
| 2026-11-23 | 36C77026P0114 | HYGEN PHARMACEUTICALS INC | $47,079 |
| 2026-11-30 | 15B21827F00000007 | MCKESSON CORPORATION | $7,748 |
| 2026-11-30 | 36C26023P0532 | CARDINAL HEALTH 414, LLC | $1,036,097 |
| 2026-12-07 | 36C24726P0690 | SINA DRUG LLC | $188,463 |
| 2026-12-11 | 15B10627F00000020 | MCKESSON CORPORATION | $6,600,000 |
| 2026-12-11 | 15B20527F00000022 | MCKESSON CORPORATION | $2,000,000 |
| 2026-12-11 | 15B50927F00000005 | MCKESSON CORPORATION | $1,256,332 |
| 2026-12-14 | 36C24723F0136 | PROGENICS PHARMACEUTICALS INC | $6,518,339 |
| 2026-12-14 | 36C25226P0108 | EXELAN PHARMACEUTICALS INC | $2,500,000 |
| 2026-12-14 | 36C25226P0110 | EXELAN PHARMACEUTICALS INC | $1,400,435 |
| 2026-12-19 | 36C24926N0263 | ADVANCED ACCELERATOR APPLICATIONS USA, INC. | $5,075,550 |
| 2026-12-21 | 75H71226F80005 | MCKESSON CORPORATION | $1,600,000 |
| 2026-12-23 | 36C77026P0131 | MELLING LLC | $686,704 |
| 2026-12-31 | 15B61926F00000149 | MCKESSON CORPORATION | $25,648 |